34 related articles for article (PubMed ID: 38760458)
1. TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapy.
Di Luccia B; Molgora M; Khantakova D; Jaeger N; Chang HW; Czepielewski RS; Helmink BA; Onufer EJ; Fachi JL; Bhattarai B; Trsan T; Rodrigues PF; Hou J; Bando JK; da Silva CS; Cella M; Gilfillan S; Schreiber RD; Gordon JI; Colonna M
Sci Immunol; 2024 May; 9(95):eadi5374. PubMed ID: 38758808
[TBL] [Abstract][Full Text] [Related]
2. Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.
Murayama M; Hosonuma M; Kuramasu A; Kobayashi S; Sasaki A; Baba Y; Narikawa Y; Toyoda H; Isobe J; Funayama E; Tajima K; Sasaki A; Maruyama Y; Yamazaki Y; Shida M; Hamada K; Hirasawa Y; Tsurui T; Ariizumi H; Ishiguro T; Suzuki R; Ohkuma R; Kubota Y; Horiike A; Sambe T; Tsuji M; Wada S; Kobayashi S; Shimane T; Tsunoda T; Kobayashi H; Kiuchi Y; Yoshimura K
Sci Rep; 2024 May; 14(1):11325. PubMed ID: 38760458
[TBL] [Abstract][Full Text] [Related]
3. Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer.
Ziemons J; Aarnoutse R; Heuft A; Hillege L; Waelen J; de Vos-Geelen J; Valkenburg-van Iersel L; van Hellemond IEG; Creemers GM; Baars A; Vestjens JHMJ; Penders J; Venema K; Smidt ML
Clin Exp Med; 2023 Nov; 23(7):3919-3933. PubMed ID: 37027066
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome and health: mechanistic insights.
de Vos WM; Tilg H; Van Hul M; Cani PD
Gut; 2022 May; 71(5):1020-1032. PubMed ID: 35105664
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy.
Hamada K; Yoshimura K; Hirasawa Y; Hosonuma M; Murayama M; Narikawa Y; Ariizumi H; Ohkuma R; Shida M; Kubota Y; Matsukuma S; Ishiguro T; Sambe T; Horiike A; Kuramasu A; Wada S; Tsurutani J; Inoue E; Uchida N; Kiuchi Y; Kobayashi S; Hoffman RM; Tsunoda T
Anticancer Res; 2021 Oct; 41(10):4985-4993. PubMed ID: 34593446
[TBL] [Abstract][Full Text] [Related]
6. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
Sánchez-Alcoholado L; Laborda-Illanes A; Otero A; Ordóñez R; González-González A; Plaza-Andrades I; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502456
[TBL] [Abstract][Full Text] [Related]
7. Microbial short-chain fatty acids modulate CD8
Luu M; Riester Z; Baldrich A; Reichardt N; Yuille S; Busetti A; Klein M; Wempe A; Leister H; Raifer H; Picard F; Muhammad K; Ohl K; Romero R; Fischer F; Bauer CA; Huber M; Gress TM; Lauth M; Danhof S; Bopp T; Nerreter T; Mulder IE; Steinhoff U; Hudecek M; Visekruna A
Nat Commun; 2021 Jul; 12(1):4077. PubMed ID: 34210970
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Davar D; Dzutsev AK; McCulloch JA; Rodrigues RR; Chauvin JM; Morrison RM; Deblasio RN; Menna C; Ding Q; Pagliano O; Zidi B; Zhang S; Badger JH; Vetizou M; Cole AM; Fernandes MR; Prescott S; Costa RGF; Balaji AK; Morgun A; Vujkovic-Cvijin I; Wang H; Borhani AA; Schwartz MB; Dubner HM; Ernst SJ; Rose A; Najjar YG; Belkaid Y; Kirkwood JM; Trinchieri G; Zarour HM
Science; 2021 Feb; 371(6529):595-602. PubMed ID: 33542131
[TBL] [Abstract][Full Text] [Related]
9. Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications.
Shi F; Li Y; Han R; Fu A; Wang R; Nusbaum O; Qin Q; Chen X; Hou L; Zhu Y
Sci Rep; 2021 Jan; 11(1):2519. PubMed ID: 33510252
[TBL] [Abstract][Full Text] [Related]
10. Identification of lysine isobutyrylation as a new histone modification mark.
Zhu Z; Han Z; Halabelian L; Yang X; Ding J; Zhang N; Ngo L; Song J; Zeng H; He M; Zhao Y; Arrowsmith CH; Luo M; Bartlett MG; Zheng YG
Nucleic Acids Res; 2021 Jan; 49(1):177-189. PubMed ID: 33313896
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.
Baruch EN; Youngster I; Ben-Betzalel G; Ortenberg R; Lahat A; Katz L; Adler K; Dick-Necula D; Raskin S; Bloch N; Rotin D; Anafi L; Avivi C; Melnichenko J; Steinberg-Silman Y; Mamtani R; Harati H; Asher N; Shapira-Frommer R; Brosh-Nissimov T; Eshet Y; Ben-Simon S; Ziv O; Khan MAW; Amit M; Ajami NJ; Barshack I; Schachter J; Wargo JA; Koren O; Markel G; Boursi B
Science; 2021 Feb; 371(6529):602-609. PubMed ID: 33303685
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance.
Bagchi S; Yuan R; Engleman EG
Annu Rev Pathol; 2021 Jan; 16():223-249. PubMed ID: 33197221
[TBL] [Abstract][Full Text] [Related]
13. Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor.
Han R; Nusbaum O; Chen X; Zhu Y
Mol Ther Oncolytics; 2020 Dec; 19():8-18. PubMed ID: 33024815
[TBL] [Abstract][Full Text] [Related]
14. An Overview on Fecal Branched Short-Chain Fatty Acids Along Human Life and as Related With Body Mass Index: Associated Dietary and Anthropometric Factors.
Rios-Covian D; González S; Nogacka AM; Arboleya S; Salazar N; Gueimonde M; de Los Reyes-Gavilán CG
Front Microbiol; 2020; 11():973. PubMed ID: 32547507
[TBL] [Abstract][Full Text] [Related]
15. Interaction between microbiota and immunity in health and disease.
Zheng D; Liwinski T; Elinav E
Cell Res; 2020 Jun; 30(6):492-506. PubMed ID: 32433595
[TBL] [Abstract][Full Text] [Related]
16. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors.
Nomura M; Nagatomo R; Doi K; Shimizu J; Baba K; Saito T; Matsumoto S; Inoue K; Muto M
JAMA Netw Open; 2020 Apr; 3(4):e202895. PubMed ID: 32297948
[TBL] [Abstract][Full Text] [Related]
17. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health.
Oliphant K; Allen-Vercoe E
Microbiome; 2019 Jun; 7(1):91. PubMed ID: 31196177
[TBL] [Abstract][Full Text] [Related]
18. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.
Tanoue T; Morita S; Plichta DR; Skelly AN; Suda W; Sugiura Y; Narushima S; Vlamakis H; Motoo I; Sugita K; Shiota A; Takeshita K; Yasuma-Mitobe K; Riethmacher D; Kaisho T; Norman JM; Mucida D; Suematsu M; Yaguchi T; Bucci V; Inoue T; Kawakami Y; Olle B; Roberts B; Hattori M; Xavier RJ; Atarashi K; Honda K
Nature; 2019 Jan; 565(7741):600-605. PubMed ID: 30675064
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
